The assessment discusses fifty eight peptides in numerous clinical phases, indicating a sturdy pipeline of peptide therapies focusing on PPIs. In this way, peptide-primarily based drug development may very well be sizeable for your future of qualified remedy.4 PEGylation of therapeutic peptides and proteins by using genetic code expansion. Az